Taiho Oncology Discontinued
FDA Approved Drugs
Taiho Oncology Discontinued
FDA Approved Drugs Database
FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.
- Total Records 1
- Latest Approval Date Jul 28, 2025
- Data Source FDA
- First Approval Date Jul 28, 2025
Company Overview
Social Profiles
Company Snapshot
Taiho Oncology Discontinued
101 Carnegie Center, Suite 101 Princeton, New Jersey 08540
U.S.A
www.taihooncology.com/us/ View on MapFDA Approved Drug Records ( 1 record )
Related Databases
-
FDA Inspections
0 View
-
EDQM CEP
0 View
-
KDMF
0 View
-
Japan DMF
0 View
-
Eudra GMP
0 View
-
NDC Database
0 View
-
FDA Approved Drugs Database
5 View
-
Drug Prices in Switzerland
0 View
Drug Status Breakdown
1 total- Discontinued
Official Source
FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.
Visit FDA Orange BookFDA Approved Drug Record Details Preview
Explore important FDA approved drug information available in the records above.
Drug Name
LYTGOBI
Application Number
214801
Product Number
2
Active Ingredient
FUTIBATINIB
Dosage Form
-
Strength
16MG
FDA Approved Drug Data
Approved drug product information
Regular Updates
Data maintained from official sources
Structured Database
Searchable pharmaceutical data
Reliable Data
Organized FDA drug records
Create a New Buying Request
Fields marked with * are mandatory.